Last, we must also emphasize that the modulation of COX-2 expression, as a representation of chronic inflammation, may require a prolonged therapeutic regimen, which could promote synergism with anti-CTLA-4 to improve NK cell activity against HGSOC tumor cells. The gene discussed is CTLA4; the disease is neoplasm.